ESTRO 2024 - Abstract Book

S2132

Clinical - Upper GI

ESTRO 2024

relationship between nutritional well-being and the feasibility of successful treatment in carcinoma oesophagus patients undergoing neoadjuvant chemoradiation.

Conclusion:

Our findings suggest that poor nutritional status has a significant impact on treatment tolerance in carcinoma esophagus patients undergoing neoadjuvant chemoradiation. Recognizing and addressing nutritional challenges in these patients is a crucial parameter to improve treatment outcomes. 1,2,3 These results underscore the urgent need for a comprehensive, multidisciplinary approach to address nutritional challenges in carcinoma esophagus patients. Such an approach should encompass early nutritional assessment, tailored interventions, and close monitoring throughout the course of neoadjuvant chemoradiation. By prioritizing nutritional well-being alongside treatment strategies, we may bridge the care gap and improve the prospects of successful management for carcinoma esophagus, ultimately enhancing the quality of care and outcomes for these patients. Further research and the development of evidence-based guidelines are warranted to advance the understanding and management of this complex clinical issue.

Keywords: Ca Esophagus, Neo-adjuvant Chemoradiation

References:

1. Jordan T, Mastnak DM, Palamar N, Kozjek NR. Nutritional Therapy for Patients with Esophageal Cancer. Nutr Cancer. 2018 Jan;70(1):23-29.

2. Cheng, K.K., Day, N.E. Nutrition and esophageal cancer. Cancer Causes Control 7, 33 – 40 (1996)

3. Chen H, Tucker KL, Graubard BI, Heineman EF, Markin RS, Potischman NA, Russell RM, Weisenburger DD, Ward MH. Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutrition and cancer. 2002

162

Mini-Oral

DOSE-ESCALATED SBRT IN ADVANCED PANCREATIC CANCER. FEASIBILITY, SAFETY: PRELIMINARY CLINICAL RESULTS

Bárbara Salas 1 , Laura Ferrera-Alayón 1 , Alberto Espinosa-López 2 , Andrés Vera-Rosas 3 , Elisa Salcedo 3 , Antonio Alayón 1 , Rodolfo Chicas-Sett 4 , Marta Llorez 1 , Pedro Lara 5,6 1 University Hospital Dr Negrin, Radiation Oncology, Las Palmas de Gran Canaria, Spain. 2 University Hospital Virgen de la Arrixaca, Radiation Oncology, Murcia, Spain. 3 University Hospital Dr Negrin, Radiation Oncology, Las Palmas de Gran Canaria, Spain. 4 Ascires Grupo Biomédico, Radiation Oncology, Valencia, Spain. 5 Instituto Canario de Investigación del cáncer ICIC, Radiation Oncology, Las Palmas de Gran Canaria, Spain. 6 University Hospital San Roque, Radiation Oncology, Las Palmas de Gran Canaria, Spain